Assessment Guided Neurofeedback for ASD
Controlled research on EEG connectivity training shows 40% reduction
Coben, R. & Padolsky, 1. (2006).
Assessment Guided Neurofeedback for Autistic Spectrum Disorder.
Manuscript under review with the Journal of Neurotherapy.
Background. Research reviewing the epidemiology of Autism (Medical
Research Council, 2001) indicated that approximately 60 per 10,000
children (1/166) are diagnosed with Autistic Spectrum Disorder (ASD).
Jarusiewicz (2002) published the only controlled study documenting the
effectiveness of neurofeedback for Autism based on one outcome measure.
The present study extended these findings with a larger sample size,
broader range of assessments, and physiological measures of brain
Methods. Assessment-guided neurofeedback was conducted in 20
sessions for 37 patients with ASD. The experimental and control groups
were matched for age, gender, race, handedness, other treatments, and
severity of ASD.
Results. Improved ratings of ASD symptoms reflected an 89%
success rate (p < .0001). Paired sample t-tests indicated
statistically significant improvement in Autistics who received
Neurofeedback compared to the control group. Other major findings
included: 40% reduction (p < .0001) in core ASD symptomatology
(indicated by ATEC Total Scores), and 77% (p=.0392) of the experimental
group had decreased hyperconnectivity or no change. Reduced cerebral
hyperconnectivity was associated with positive clinical outcomes in this
population. In all cases of reported improvement in ASD symptomatology,
positive treatment outcomes were confirmed by neuropsychological and
Conclusions. Evidence from multiple measures has demonstrated
that neurofeedback can be an effective treatment for ASD. In this
population, a crucial factor in explaining improved clinical outcomes in
the experimental group may be the use of assessment-guided
neurofeedback to reduce cerebral hyperconnectivity. Implications of
these findings are discussed.
Full Article: http://thebrainlabs.com/assessguidednfasd.pdf